top of page

About Me

In 2009, I was diagnosed with multiple sclerosis (MS). In the hope of making sense of such an unpredictable disease, I started learning as much as I could about MS:

attending conferences, interviewing healthcare professionals and writing articles as author/co-author for publications such as The BMJ, Nature Reviews Neurology and Neurology.

 

Through my family foundation in Canada, I also began supporting a wide range of MS initiatives, including the establishment of the Rachel Horne Prize for Women's Research in MS - an international, annual award of US$40,000, which celebrates women scientists making significant contributions to women’s health-related research in MS.

 

I am co-chair of the Patient and Public Engagement Group – part of the National Institute of Health Research (NIHR) Policy Research Unit in Dementia and Neurodegeneration based at Queen Mary University of London (QMUL). Since 2022, I have been an Honorary Research Fellow at QMUL.

 

I live in London with my husband and we have two adult children.  I am currently on Ocrevus, my third disease-modifying therapy to treat my MS.

Rachel Horne, founder of the Rachel Horne Prize, with 2024 prize winner, Professor Kirsten Hellwig

With 2024 prize winner Professor Kirsten Hellwig

​Non-MS philanthropy

Over the years, I have donated to a number of projects which have supported women and girls around the world.

 

These include regular contributions to Ethiopiaid Canada and their partner AWSAD, a charity which runs safe houses in Ethiopia for survivors of domestic violence and abuse. I also give annually to Friends of Ibba Girls' School, a residential girls' school in Southern Sudan.

Rachel Horne at the AWSAD Safe House in Addis Adaba, Ethiopia

At the AWSAD Safe House, Addis Ababa, Ethiopia

© 2025 by Rachel Horne

Powered and secured by Wix

  • X
  • Linkedin
bottom of page